Expression patterns of T-type Cav3.2 channel and insulin-like growth factor-1 receptor in dorsal root ganglion neurons of mice after sciatic nerve axotomy
暂无分享,去创建一个
[1] B. Wang,et al. Colocalization of insulin-like growth factor-1 receptor and T type Cav3.2 channel in dorsal root ganglia in chronic inflammatory pain mouse model , 2016, Neuroreport.
[2] B. Wang,et al. TLR signaling adaptor protein MyD88 in primary sensory neurons contributes to persistent inflammatory and neuropathic pain and neuroinflammation , 2016, Scientific Reports.
[3] S. Laffray,et al. T-type calcium channels in neuropathic pain , 2016, Pain.
[4] Y. Zhang,et al. Peripheral pain is enhanced by insulin-like growth factor 1 through a G protein–mediated stimulation of T-type calcium channels , 2014, Science Signaling.
[5] C. Bladen,et al. The Deubiquitinating Enzyme USP5 Modulates Neuropathic and Inflammatory Pain by Enhancing Cav3.2 Channel Activity , 2014, Neuron.
[6] Zhen-Zhong Xu,et al. Nociceptive neurons regulate innate and adaptive immunity and neuropathic pain through MyD88 adapter , 2014, Cell Research.
[7] C. Bladen,et al. 1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain , 2014, Pflügers Archiv - European Journal of Physiology.
[8] V. Jevtovic-Todorovic,et al. CaV3.2 T-Type Calcium Channels in Peripheral Sensory Neurons Are Important for Mibefradil-Induced Reversal of Hyperalgesia and Allodynia in Rats with Painful Diabetic Neuropathy , 2014, PloS one.
[9] G. Zamponi,et al. Neuronal Voltage-Gated Calcium Channels: Structure, Function, and Dysfunction , 2014, Neuron.
[10] V. Jevtovic-Todorovic,et al. Targeting of CaV3.2 T-type calcium channels in peripheral sensory neurons for the treatment of painful diabetic neuropathy , 2014, Pflügers Archiv - European Journal of Physiology.
[11] C. Altier,et al. Calcium-permeable ion channels in pain signaling. , 2014, Physiological reviews.
[12] Seungkyu Lee. Pharmacological Inhibition of Voltage-gated Ca2+ Channels for Chronic Pain Relief , 2013, Current neuropharmacology.
[13] P. Barrett,et al. Reversal of Neuropathic Pain in Diabetes by Targeting Glycosylation of Cav3.2 T-Type Calcium Channels , 2013, Diabetes.
[14] R. Mason,et al. Curcumin and its Derivatives: Their Application in Neuropharmacology and Neuroscience in the 21st Century , 2013, Current neuropharmacology.
[15] C. Bladen,et al. Surface expression and function of Cav3.2 T-type calcium channels are controlled by asparagine-linked glycosylation , 2013, Pflügers Archiv - European Journal of Physiology.
[16] B. Shu,et al. Upregulation of T-type Ca2+ Channels in Primary Sensory Neurons in Spinal Nerve Injury , 2013, Spine.
[17] Xu Zhang,et al. Activin C expressed in nociceptive afferent neurons is required for suppressing inflammatory pain. , 2012, Brain : a journal of neurology.
[18] 三浦 真由美. Peripheral sensitization caused by insulin-like growth factor 1 contributes to pain hypersensitivity after tissue injury , 2012 .
[19] V. Jevtovic-Todorovic,et al. T‐type voltage‐gated calcium channels as targets for the development of novel pain therapies , 2011, British journal of pharmacology.
[20] M. Sekiguchi,et al. Localization and Function of Insulin-like Growth Factor 1 in Dorsal Root Ganglia in a Rat Disc Herniation Model , 2011, Spine.
[21] Ya-Ting Chang,et al. Cav3.2 T-Type Ca2+ Channel-Dependent Activation of ERK in Paraventricular Thalamus Modulates Acid-Induced Chronic Muscle Pain , 2010, The Journal of Neuroscience.
[22] Shiyuan Xu,et al. The Roles of T-Type Calcium Channel in the Development of Neuropathic Pain following Chronic Compression of Rat Dorsal Root Ganglia , 2010, Pharmacology.
[23] A. Eschalier,et al. T-Type Calcium Channel Inhibition Underlies the Analgesic Effects of the Endogenous Lipoamino Acids , 2009, The Journal of Neuroscience.
[24] M. Sekiguchi,et al. Gene Expression Changes in Dorsal Root Ganglion of Rat Experimental Lumber Disc Herniation Models , 2008, Spine.
[25] V. Jevtovic-Todorovic,et al. Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve. , 2008, Journal of neurophysiology.
[26] K. Campbell,et al. Attenuated pain responses in mice lacking CaV3.2 T‐type channels , 2007, Genes, brain, and behavior.
[27] D. Bayliss,et al. Cell-Specific Alterations of T-Type Calcium Current in Painful Diabetic Neuropathy Enhance Excitability of Sensory Neurons , 2007, The Journal of Neuroscience.
[28] Patrick Delmas,et al. Pharmacological Dissection and Distribution of NaN/Nav1.9, T-type Ca2+ Currents, and Mechanically Activated Cation Currents in Different Populations of DRG Neurons , 2007, The Journal of general physiology.
[29] S. Todorovic,et al. Is there a role for T-type calcium channels in peripheral and central pain sensitization? , 2006, Molecular Neurobiology.
[30] B. A. Forshee. The aging brain: is function dependent on growth hormone/insulin-like growth factor-1 signaling? , 2006, AGE.
[31] Olivier Poirot,et al. Silencing of the Cav3.2 T‐type calcium channel gene in sensory neurons demonstrates its major role in nociception , 2005, The EMBO journal.
[32] C. Pierson,et al. Insulin Deficiency Rather than Hyperglycemia Accounts for Impaired Neurotrophic Responses and Nerve Fiber Regeneration in Type 1 Diabetic Neuropathy , 2003, Journal of neuropathology and experimental neurology.
[33] S. Waxman,et al. Preferential expression of IGF-I in small DRG neurons and down-regulation following injury , 2002, Neuroreport.
[34] Michael Nilsson,et al. Insulin-like growth factor-I and neurogenesis in the adult mammalian brain. , 2002, Brain research. Developmental brain research.